Reversible Increase in Resistance of A-431 Carcinoma Cells to TRAIL-Induced Apoptosis in Confluent Cultures Corresponds to a Decrease in Expression of DR4 and DR5 Receptors

Chamuleau M.E., Ossenkoppele G.J., van Rhenen A., van Dreunen, L., Jirka S.M., Zevenbergen A., Schuurhuis G.J., van de Loosdrecht A.A. 2011. High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2. Leuk. Res. 35, 741–749.

Article  CAS  PubMed  Google Scholar 

Cheng J., Hylander B.L., Baer M.R., Chen X., Repasky E.A. 2006. Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL. Mol. Cancer Ther. 5, 1844–1853.

Article  CAS  PubMed  Google Scholar 

Riccioni R., Pasquini L., Mariani G., Saulle E., Rossini A., Diverio D., Pelosi E., Vitale A., Chierichini A., Cedrone M., Foa R., Coco F., Peschle C., Testa U. 2005. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL. Haematologica. 90, 612–624.

CAS  PubMed  Google Scholar 

Buchsbaum D.J., Zhou T., Lobuglio A.F. 2006.TRAIL receptor-targeted therapy. Future Oncol. 2, 493–508.

Article  CAS  PubMed  Google Scholar 

Zhang L., Fang B. 2005. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Therapy. 12, 228–237.

Article  CAS  PubMed  Google Scholar 

Grayson K.A., Jyotsana N., Ortiz-Otero N., King M.R. 2011. Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes. PLoS One. 16 (3), e0246733.

Article  Google Scholar 

Chandrasekaran S., Marshall J.R., Messing J.A., Hsu J.W., King M.R. 2014. TRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroids. PLoS One. 9 (10), e111487.

Article  PubMed  PubMed Central  Google Scholar 

Fadeev P.S., Chekanov A.V., Dolgikh N.V., Akatov V.S. 2012. Enhancement of resistance of A431 tumor cells to TRAIL-induced apoptosis in confluent cultures. Biofizika (Rus.). 57 (4), 649–654.

CAS  Google Scholar 

Dolgikh N.V., Chekanov A.V., Fadeev R.S., Akatov V.S. 2017. Differences in activation of A431 tumor cell signaling pathways in confluent-dependent and confluent-independent TRAIL resistance. Biol. Membranes (Rus.). 34 (6), 124–136.

CAS  Google Scholar 

Kobyakova M., Lomovskaya Y., Senotov A., Lomovsky A., Minaychev V., Fadeeva I., Shtatnova D., Krasnov K., Zvyagina A., Odinokova I., Akatov V., Fadeev R. 2022. The increase in the drug resistance of acute myeloid leukemia THP-1 cells in high-density cell culture is associated with inflammatory-like activation and anti-apoptotic Bcl-2 proteins. Int. J. Mol. Sci. 23, 7881.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lomovskaya Y.V., Kobyakova M.I., Senotov A.S., L-omovsky A.I., Minaychev V.V., Fadeeva I.S., Shtatnova D.Y., Krasnov K.S., Zvyagina A.I., Akatov V.S., Fadeev R.S. 2022. Macrophage-like THP-1 cells derived from high-density cell culture are resistant to TRAIL-induced cell death via down-regulation of death-receptors DR4 and DR5. Biomolecules. 12, 150.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suzuki K., Hiroaki H., Kohda D., Tanaka T. 1998. An isoleucine zipper peptide forms a native-like triple stranded coiled coil in solution. Protein Eng. 11, 1051–1055.

Article  CAS  PubMed  Google Scholar 

Fadeev R., Chekanov A., Solovieva M., Bezborodova O., Nemtsova E., Dolgikh N., Fadeeva I., Senotov A., Kobyakova M., Evstratova Y., Yakubovskaya R., Akatov V. 2019. Improved anticancer effect of recombinant protein izTRAIL combined with sorafenib and peptide iRGD. Int. J. Mol. Sci. 20, 525.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lomovsky A., Baburina Y., Odinokova I., Kobyakova M., Evstratova Y., Sotnikova L., Krestinin R., Krestinina O. 2020. Melatonin can modulate the effect of navitoclax (ABT-737) in HL-60 cells. Antioxidants. 9, 1143.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lavrik I.N., Krammer P.H. 2012. Regulation of CD95/Fas signaling at the DISC. Cell Death Differ. 19 (1), 36–41.

Article  CAS  PubMed  Google Scholar 

Galluzzi L., Maiuri M., Vitale I., Zischka H., Castedo M., Zitvogel L., Kroemer G. 2007. Cell death modalities: Classification and pathophysiological implications. Cell Death Differ. 14 (7), 1237-43.

Article  CAS  PubMed  Google Scholar 

Waterhouse N., Sedelies K., Sutton V. Pinkoski M., Thia K., Johnstone R., Bird P., Green D., Trapani J. 2006. Functional dissociation of ΔΨm and cytochrome c release defines the contribution of mitochondria upstream of caspase activation during granzyme B-induced apoptosis. Cell Death Differ. 13, 607–618.

Article  CAS  PubMed  Google Scholar 

Zou H., Henzel W., Liu X., Lutschg A., Wang X. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90 (3), 405–413.

Article  CAS  PubMed  Google Scholar 

Dida F., Li Y., Iwao A., Deguchi T., Azuma E., Komada Y. 2008. Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cells. Exp. Hematology. 36 (10), 1343–1353.

Article  CAS  Google Scholar 

留言 (0)

沒有登入
gif